(Q43182167)

15 November 2017

title

Weekly docetaxel, cisplatin, and 5-fluorouracil as initial therapy for patients with advanced gastric and esophageal cancer (English)

1 reference

15 November 2017

1 reference

1 reference

1 reference

8

Jaffer Ajani

1 reference

15 November 2017

Michael J Overman

1

1 reference

15 November 2017

Syed M Kazmi

2

1 reference

15 November 2017

Jagriti Jhamb

3

1 reference

15 November 2017

E Lin

4

1 reference

15 November 2017

James C Yao

5

1 reference

15 November 2017

James L Abbruzzese

6

1 reference

15 November 2017

Linus Ho

7

1 reference

15 November 2017

Alexandria Phan

9

1 reference

15 November 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

15 November 2017

1 reference

15 November 2017

volume

116

1 reference

15 November 2017

issue

6

1 reference

15 November 2017

page(s)

1446-1453

1 reference

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24925

7 January 2021

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24925

7 January 2021

Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24925

7 January 2021

Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24925

7 January 2021

Docetaxel, cisplatin, and fluorouracil in gastric cancer: does the punishment fit the crime?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24925

7 January 2021

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24925

7 January 2021

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24925

7 January 2021

Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24925

7 January 2021

The role of weekly docetaxel in the treatment of advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24925

7 January 2021

A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24925

7 January 2021

Comparison of comorbidity prevalence in oesophageal and gastric carcinoma patients: a population-based study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24925

7 January 2021

Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24925

7 January 2021

Referral Patterns, Treatment Choices, and Outcomes in Locoregional Esophageal Cancer: A Population-Based Analysis of Elderly Patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24925

7 January 2021

Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24925

7 January 2021

Phase II study of low-dose docetaxel/fluorouracil/cisplatin in metastatic gastric carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24925

7 January 2021

Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24925

7 January 2021

Identifiers

DOI

10.1002/CNCR.24925

1 reference

15 November 2017

1 reference